Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.

Lung cancer is among the most frequent ... is a cornerstone of palliative care and involves a multimodal approach. Assessment ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

A seemingly healthy 76-year-old man who suffered with a wobbly tooth and jaw ache was devastated to find his pain was the result of advanced prostate cancer. The man visited a dentist who ...

A positive phase 2b trial results of XG005 treatment in chronic osteoarthritis pain was recently reported, and a Phase 2 trial of XG005 in cancer-induced bone pain is currently ongoing in Taiwan ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

and to pinpoint people with melanoma who are most likely to experience a recurrence of their cancer. The researchers named the model MUSK, for multimodal transformer with unified mask modeling.